Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk
Article Information
vol. 64 no. 4 1470-1483
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 2, 2014
- Accepted October 29, 2014
- Published in print March 24, 2015.
- Published online ahead of print November 3, 2014.
Article Versions
- Previous version (November 3, 2014 - 12:40).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Author Information
- Ayellet V. Segrè1,2,
- Nancy Wei3,4,
- DIAGRAM Consortium*,
- MAGIC Investigators*,
- David Altshuler1,2,3,4,5,6,7 and
- Jose C. Florez1,3,4,5⇑
- 1Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA
- 2Department of Molecular Biology, Massachusetts General Hospital, Boston, MA
- 3Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston, MA
- 4Department of Medicine, Harvard Medical School, Boston, MA
- 5Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA
- 6Department of Genetics, Harvard Medical School, Boston, MA
- 7Department of Biology, Massachusetts Institute of Technology, Cambridge, MA
- Corresponding author: Jose C. Florez, jcflorez{at}partners.org.
Statistics from Altmetric.com
Article usage
In this Issue
April 2015, 64(4)
Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk
